| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |